Transition amid governance reviews and safety investigations continues Interim finance chief brings background and public ...
Baxter International Inc. (BAX), headquartered in Deerfield, Illinois, develops and provides a portfolio of healthcare ...
Baxter International (BAX) is back in focus after a cluster of analyst downgrades and fresh legal investigations into alleged fiduciary breaches, supply chain disclosures, and Novum LVP product safety ...
Artisan Partners, an investment management company, released its “Artisan Mid Cap Value Fund” fourth quarter 2024 investor letter. A copy of the letter can be downloaded here. The Russell Midcap Value ...
Detailed price information for Baxter International Inc (BAX-N) from The Globe and Mail including charting and trades.
Artisan Partners, an investment management company, released its “Artisan Mid Cap Value Fund” first-quarter 2025 investor letter. A copy of the letter can be downloaded here. The growth stock trade ...
In recent days, Baxter International has faced renewed legal scrutiny as law firms announced investigations into alleged governance failures, product safety misstatements around its Novum LVP infusion ...
The average one-year price target for Baxter International (NYSE:BAX) has been revised to $25.43 / share. This is a decrease of 11.85% from the prior estimate of $28.85 dated November 7, 2025. The ...
The Deerfield, Illinois-based company reported sales of $3.85 billion, in line with consensus. Baxter’s worldwide sales include continuing sales of $2.69 billion and discontinued operations (kidney ...
The average one-year price target for Baxter International (WBAG:BAX) has been revised to € 21,88 / share. This is a decrease of 11.75% from the prior estimate of € 24,80 dated November 9, 2025. The ...
Detailed price information for Baxter International Inc (BAX-N) from The Globe and Mail including charting and trades.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results